Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification and Characterization of Commercial RUO Antibodies for the Detection of Specific Breast Cancer Tumoral Markers Expressed in Potential Circulating Tumoral Cells (CTCs)

NCT05054010 is registered in ClinicalTrials.gov with Tethis S.p.A. as lead sponsor.

NCT NCT05054010
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05054010 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification and Characterization of Commercial RUO Antibodies for the Detection of Specific Breast Cancer Tumoral Markers Expressed in Potential Circulating Tumoral Cells (CTCs)
Lead sponsor
Tethis S.p.A.
Phase
Observational
Overall status
Active, not recruiting
Start date
October 4, 2021
Completion date
December 31, 2026
Enrollment
84 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasms